Advances in Drugs Targeting Lymphangiogenesis for Preventing Tumor Progression and Metastasis
Metastasis of cancer cells from the primary tumor to other organs and tissues in the body is the leading cause of death in patients with malignancies. One of the principal ways cancer cells travel is through lymphatic vessels, and tumor invasion into the regional lymph nodes is a hallmark of early m...
Main Authors: | Chuqi Wang, Ming Chu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-01-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.783309/full |
Similar Items
-
Two Birds, One Stone: Double Hits on Tumor Growth and Lymphangiogenesis by Targeting Vascular Endothelial Growth Factor Receptor 3
by: Ming-Chuan Hsu, et al.
Published: (2019-03-01) -
Effects of inhibition of lymphangiogenesis by the vascular endothelial growth factor receptor 3 (VEGFR-3) inhibitor, MAZ51 on full thickness wounds in mice
by: Kana Takada, et al.
Published: (2021-03-01) -
Breaking a Vicious Circle: Lymphangiogenesis as a New Therapeutic Target in Wound Healing
by: Filippo Renò, et al.
Published: (2023-02-01) -
Characterizing Lymphangiogenesis and Concurrent Inflammation in Adipose Tissue in Response to VEGF-D
by: Adri Chakraborty, et al.
Published: (2020-04-01) -
Angiogenesis and Lymphangiogenesis in Medulloblastoma Development
by: Manon Penco-Campillo, et al.
Published: (2023-07-01)